Literature DB >> 15844872

History of acoustic neurinoma surgery.

Theofilos G Machinis1, Kostas N Fountas, Vassilios Dimopoulos, Joe Sam Robinson.   

Abstract

The purpose of this article is to provide insight into the development of surgery for acoustic neurinomas throughout the years. The significant contribution of surgical authorities such as Cushing, Dandy, and House are discussed. The advances in surgical techniques from the very first operations for acoustic tumors at the end of the 19th century until today are described, with special emphasis on the technological and diagnostic milestones that preceded each step of this development.

Entities:  

Mesh:

Year:  2005        PMID: 15844872     DOI: 10.3171/foc.2005.18.4.10

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  12 in total

1.  An integrated system for planning, navigation and robotic assistance for skull base surgery.

Authors:  Tian Xia; Clint Baird; George Jallo; Kathryn Hayes; Nobuyuki Nakajima; Nobuhiko Hata; Peter Kazanzides
Journal:  Int J Med Robot       Date:  2008-12       Impact factor: 2.547

2.  Harvey Cushing, the spine surgeon: the surgical treatment of Pott disease.

Authors:  Ali Bydon; Hormuzdiyar H Dasenbrock; Courtney Pendleton; Matthew J McGirt; Ziya L Gokaslan; Alfredo Quinones-Hinojosa
Journal:  Spine (Phila Pa 1976)       Date:  2011-08-01       Impact factor: 3.468

3.  Solid hemangioblastoma of vestibular nerve mimicking vestibular schwannoma.

Authors:  Gordan Grahovac
Journal:  Neurol Sci       Date:  2015-04-22       Impact factor: 3.307

4.  The anatomical location and course of the facial nerve in vestibular schwannomas : a study of 163 surgically treated cases.

Authors:  Chae Wan Bae; Young Hyun Cho; Seok Ho Hong; Jeong Hoon Kim; Jung-Kyo Lee; Chang Jin Kim
Journal:  J Korean Neurosurg Soc       Date:  2007-12-20

5.  National Trends in Vestibular Schwannoma Surgery: Influence of Patient Characteristics on Outcomes.

Authors:  Jonathan L Hatch; Michael J Bauschard; Shaun A Nguyen; Paul R Lambert; Ted A Meyer; Theodore R McRackan
Journal:  Otolaryngol Head Neck Surg       Date:  2018-03-27       Impact factor: 3.497

6.  Does Hospital Volume Affect Outcomes in Patients Undergoing Vestibular Schwannoma Surgery?

Authors:  Jonathan L Hatch; Michael J Bauschard; Shaun A Nguyen; Paul R Lambert; Ted A Meyer; Theodore R McRackan
Journal:  Otol Neurotol       Date:  2018-04       Impact factor: 2.311

7.  Microsurgical excisions of vestibular schwannomas: A tumor-size-based analysis of neurological outcomes and surgical complications.

Authors:  Syed Faraz Kazim; Muhammad Shahzad Shamim; Syed Ather Enam; Muhammad Ehsan Bari
Journal:  Surg Neurol Int       Date:  2011-03-31

Review 8.  Stereotactic Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting Standards.

Authors:  Scott G Soltys; Michael T Milano; Jinyu Xue; Wolfgang A Tomé; Ellen Yorke; Jason Sheehan; George X Ding; John P Kirkpatrick; Lijun Ma; Arjun Sahgal; Timothy Solberg; John Adler; Jimm Grimm; Issam El Naqa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-12-26       Impact factor: 8.013

9.  Surgical management for large vestibular schwannomas: a systematic review, meta-analysis, and consensus statement on behalf of the EANS skull base section.

Authors:  Daniele Starnoni; Lorenzo Giammattei; Giulia Cossu; Michael J Link; Pierre-Hugues Roche; Ari G Chacko; Kenji Ohata; Majid Samii; Ashish Suri; Michael Bruneau; Jan F Cornelius; Luigi Cavallo; Torstein R Meling; Sebastien Froelich; Marcos Tatagiba; Albert Sufianov; Dimitrios Paraskevopoulos; Idoya Zazpe; Moncef Berhouma; Emmanuel Jouanneau; Jeroen B Verheul; Constantin Tuleasca; Mercy George; Marc Levivier; Mahmoud Messerer; Roy Thomas Daniel
Journal:  Acta Neurochir (Wien)       Date:  2020-07-29       Impact factor: 2.216

10.  Surgery After Surgery for Vestibular Schwannoma: A Case Series.

Authors:  Łukasz Przepiórka; Przemysław Kunert; Wiktoria Rutkowska; Tomasz Dziedzic; Andrzej Marchel
Journal:  Front Oncol       Date:  2020-12-18       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.